Lista de obras - Kenzo Tokunaga - Dominio Público Uruguay

APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition

artículo científico publicado en 2013

All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

artículo científico publicado en 2007

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

artículo científico publicado en 2005

An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating

artículo científico publicado en 2016

Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers

artículo científico publicado en 2015

Aromatic Side Chain at Position 412 of SERINC5 Exerts Restriction Activity toward HIV-1 and Other Retroviruses

artículo científico publicado en 2021

Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins.

artículo científico publicado en 2013

Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors

artículo científico publicado en 2010

Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase

artículo científico publicado en 2016

DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition

artículo científico publicado en 2013

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

artículo científico publicado en 2010

Direct internalization of cell-surface BST-2/tetherin by the HIV-1 accessory protein Vpu ⬇️

artículo científico publicado el 1 de julio de 2010

Early replication block of human immunodeficiency virus type 1 in monkey cells

artículo científico publicado en 1995

Editorial: HIV-1 Vpu and BST-2/Tetherin: Enemies at the Gates ⬇️

artículo científico publicado el 1 de junio de 2012

Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent.

artículo científico publicado en 1998

Epigenetic displacement of HP1 from heterochromatin by HIV-1 Vpr causes premature sister chromatid separation.

artículo científico publicado en 2011

Evaluation of telomerase activity in non-genital Bowen's disease.

artículo científico publicado en 2009

Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells.

artículo científico publicado en 1993

Function of human immunodeficiency virus type 1 Vpu protein in various cell types.

artículo científico publicado en 1995

Functional analysis of human spuma retrovirus genome

artículo científico publicado en 1995

Functionality of chimeric Rev proteins of HIV/SIV.

artículo científico publicado en 1995

Generation and characterization of a host cell-dependent gag gene mutant of human immunodeficiency virus type 1.

artículo científico publicado en 1995

Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand

artículo científico publicado en 2009

HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination

article

HIV-1 Vpr induces DNA double-strand breaks

artículo científico publicado en 2006

HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors

artículo científico publicado en 2005

Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation.

artículo científico publicado en 2016

Host restriction factors in retroviral infection: promises in virus-host interaction

artículo científico publicado en 2012

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

artículo científico publicado en 2004

Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.

artículo científico publicado en 2003

Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.

artículo científico publicado en 2011

Identification of an antiviral host transmembrane protein MARCH8.

artículo científico publicado en 2015

Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes.

artículo científico publicado en 2007

Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.

artículo científico publicado en 2014

Increased anti-HIV-1 activity of CD4 CDR3-related synthetic peptides by scrambling and further structural modifications, including D-isomerization and dimerization

artículo científico publicado en 1993

Inhibition of Human Immunodeficiency Virus Type 1 Virion Entry by Dominant-Negative Hck ⬇️

artículo científico publicado el 1 de julio de 1998

Intracellular logistics of BST-2/tetherin.

artículo científico publicado en 2012

Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons ⬇️

artículo científico publicado el 12 de marzo de 2011

MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.

artículo científico publicado en 2015

MARCH8 inhibits viral infection by two different mechanisms

artículo científico publicado en 2020

Maintenance of high virus load even after seroconversion in newborn cats acutely infected with feline immunodeficiency virus.

artículo científico publicado en 1995

Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection

scientific article published on 10 January 2019

Membrane-associated RING-CH (MARCH) 8 mediates the ubiquitination and lysosomal degradation of the transferrin receptor.

artículo científico publicado en 2013

Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry

artículo científico publicado en 2008

Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates

artículo científico publicado en 2001

Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).

artículo científico publicado en 2004

Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand

artículo científico publicado en 2008

Premature sister chromatid separation in HIV-1-infected peripheral blood lymphocytes

scientific article published on 01 September 2005

Rev-dependency of expression of human immunodeficiency virus type 1 gag and env genes

artículo científico publicado en 1995

Sites of action of HIV-1 Vpu in BST-2/tetherin downregulation.

artículo científico

Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism ⬇️

artículo científico publicado el 12 de diciembre de 2011

Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag

artículo científico publicado en 2020

Superinfection of a defective human immunodeficiency virus type 1 provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination.

artículo científico publicado en 1995

The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway

artículo científico publicado en 2014

The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry.

artículo científico publicado en 1999

The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors.

artículo científico publicado en 2010

Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cells

scientific article published on 17 December 2013

Tristetraprolin inhibits HIV-1 production by binding to genomic RNA.

artículo científico publicado en 2006

Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain

artículo científico publicado en 2010

Lista de obras de Kenzo Tokunaga

APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition

All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating

Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers

Aromatic Side Chain at Position 412 of SERINC5 Exerts Restriction Activity toward HIV-1 and Other Retroviruses

Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins.

Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors

Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase

DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

Direct internalization of cell-surface BST-2/tetherin by the HIV-1 accessory protein Vpu ⬇️

Early replication block of human immunodeficiency virus type 1 in monkey cells

Editorial: HIV-1 Vpu and BST-2/Tetherin: Enemies at the Gates ⬇️

Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent.

Epigenetic displacement of HP1 from heterochromatin by HIV-1 Vpr causes premature sister chromatid separation.

Evaluation of telomerase activity in non-genital Bowen's disease.

Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells.

Function of human immunodeficiency virus type 1 Vpu protein in various cell types.

Functional analysis of human spuma retrovirus genome

Functionality of chimeric Rev proteins of HIV/SIV.

Generation and characterization of a host cell-dependent gag gene mutant of human immunodeficiency virus type 1.

Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand

HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination

HIV-1 Vpr induces DNA double-strand breaks

HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors

Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation.

Host restriction factors in retroviral infection: promises in virus-host interaction

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.

Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.

Identification of an antiviral host transmembrane protein MARCH8.

Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes.

Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.

Increased anti-HIV-1 activity of CD4 CDR3-related synthetic peptides by scrambling and further structural modifications, including D-isomerization and dimerization

Inhibition of Human Immunodeficiency Virus Type 1 Virion Entry by Dominant-Negative Hck ⬇️

Intracellular logistics of BST-2/tetherin.

Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons ⬇️

MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.

MARCH8 inhibits viral infection by two different mechanisms

Maintenance of high virus load even after seroconversion in newborn cats acutely infected with feline immunodeficiency virus.

Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection

Membrane-associated RING-CH (MARCH) 8 mediates the ubiquitination and lysosomal degradation of the transferrin receptor.

Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry

Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates

Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).

Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand

Premature sister chromatid separation in HIV-1-infected peripheral blood lymphocytes

Rev-dependency of expression of human immunodeficiency virus type 1 gag and env genes

Sites of action of HIV-1 Vpu in BST-2/tetherin downregulation.

Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism ⬇️

Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag

Superinfection of a defective human immunodeficiency virus type 1 provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination.

The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway

The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry.

The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors.

Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cells

Tristetraprolin inhibits HIV-1 production by binding to genomic RNA.

Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain